Charles Flexner, MD, from Johns Hopkins University answers our questions about aging in HIV, long-acting antiretroviral therapy, and at-risk populations.
Do comorbidities and polypharmacy lead to virologic failure in all populations living with HIV? This was the focus of recent research presented at IDWeek 2018.
<p>In this podcast, Dr Michael Reid from&nbsp;University of California, San Francisco, discusses the prevalence of obesity in patients with HIV, HIV treatments that may lead to obesity, and other...
A new study of more than 27,000 MSM has indicated that increased HIV PrEP use has unexpectedly led to decreased condom use among men not using PrEP. Consultant360 spoke with lead study author Martin Holt,...
Dr Karin Nielsen from UCLA Mattel Children’s Hospital answers our questions about HIV in infants, mother-to-child transmission, and the future of HIV treatment.